Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
5.73
+0.02 (0.35%)
At close: Sep 24, 2026, 4:00 PM EDT
5.71
-0.02 (-0.35%)
After-hours: Sep 24, 2026, 7:45 PM EDT
Nuvation Bio Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Nuvation Bio stock has a consensus rating of "Buy" and an average price target of $13.1. The average 1-year stock price forecast is 128.62% higher than the current stock price, while the lowest is $7.00 (+22.16%) and the highest is $21 (+266.49%).
Price Target: $13.1 (+128.62%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nuvation Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 6 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $11 | Buy | Maintains | $11 | +91.97% | Sep 15, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 15, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $12 | Buy | Initiates | $12 | +109.42% | Aug 21, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +144.33% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
196.82M
from 62.90M
Increased by 212.89%
Revenue Next Year
278.85M
from 196.82M
Increased by 41.68%
EPS This Year
-0.29
from -0.49
EPS Next Year
-0.02
from -0.29
EPS and Forward PE are based on non-GAAP adjusted numbers.